NASDAQ:GRFS

Grifols News Headlines

$17.83
-0.54 (-2.94 %)
(As of 06/18/2021 12:00 AM ET)
Add
Compare
Today's Range
$17.66
$18.34
50-Day Range
$16.76
$18.94
52-Week Range
$14.81
$20.60
Volume1.46 million shs
Average Volume809,006 shs
Market Capitalization$12.26 billion
P/E Ratio18.57
Dividend Yield0.11%
Beta0.59

Grifols (NASDAQ GRFS) News Headlines Today

SourceHeadline
Grifols (NASDAQ:GRFS) Upgraded at Deutsche Bank AktiengesellschaftGrifols (NASDAQ:GRFS) Upgraded at Deutsche Bank Aktiengesellschaft
marketbeat.com - June 14 at 7:27 AM
3 Health Care Stocks That Could Double by Year End3 Health Care Stocks That Could Double by Year End
marketbeat.com - February 11 at 10:50 AM
Grifols (NASDAQ:GRFS) Upgraded by Deutsche Bank Aktiengesellschaft to "Buy"Grifols (NASDAQ:GRFS) Upgraded by Deutsche Bank Aktiengesellschaft to "Buy"
americanbankingnews.com - June 14 at 8:28 AM
Grifols, S.A. (NASDAQ:GRFS) Given Consensus Recommendation of "Buy" by BrokeragesGrifols, S.A. (NASDAQ:GRFS) Given Consensus Recommendation of "Buy" by Brokerages
americanbankingnews.com - June 13 at 1:22 AM
Grifols (NASDAQ:GRFS) Shares Gap Up to $17.65Grifols (NASDAQ:GRFS) Shares Gap Up to $17.65
americanbankingnews.com - June 11 at 10:58 AM
Grifols sees revenue contribution from new product launches to ramp by 2030 - Seeking AlphaGrifols sees revenue contribution from new product launches to ramp by 2030 - Seeking Alpha
seekingalpha.com - June 3 at 2:08 PM
Grifols to provide Korean Red Cross with Procleix Panther for blood screening, extending donor testing leadership in Asia - Yahoo FinanceGrifols to provide Korean Red Cross with Procleix Panther for blood screening, extending donor testing leadership in Asia - Yahoo Finance
finance.yahoo.com - June 3 at 12:00 AM
Form 6-K Grifols SA For: May 31 - StreetInsider.comForm 6-K Grifols SA For: May 31 - StreetInsider.com
streetinsider.com - June 1 at 6:56 PM
Grifols introduces HyperHEP B® (hepatitis B immune globulin [human]), a new formulation to treat patients exposed to hepatitis BGrifols introduces HyperHEP B® (hepatitis B immune globulin [human]), a new formulation to treat patients exposed to hepatitis B
finance.yahoo.com - June 1 at 1:48 PM
Worldwide Intravenous Solutions Industry to 2026 - Featuring Ajinomoto, Baxter International and Grifols Among Others - Yahoo Finance UKWorldwide Intravenous Solutions Industry to 2026 - Featuring Ajinomoto, Baxter International and Grifols Among Others - Yahoo Finance UK
uk.finance.yahoo.com - May 27 at 5:17 PM
Grifols (NASDAQ:GRFS)  Shares Down 4.3% Grifols (NASDAQ:GRFS) Shares Down 4.3%
americanbankingnews.com - May 27 at 1:48 PM
GigaGen Publishes Research Describing Potential New Avenues to Overcome Resistance to anti-PD-L1 Therapies - StreetInsider.comGigaGen Publishes Research Describing Potential New Avenues to Overcome Resistance to anti-PD-L1 Therapies - StreetInsider.com
streetinsider.com - May 27 at 12:16 PM
Worldwide Intravenous Solutions Industry to 2026 - Featuring Ajinomoto, Baxter International and Grifols Among Others - Yahoo FinanceWorldwide Intravenous Solutions Industry to 2026 - Featuring Ajinomoto, Baxter International and Grifols Among Others - Yahoo Finance
finance.yahoo.com - May 27 at 12:16 PM
Grifols, S.A. (NASDAQ:GRFS) Announces Semi-annual Dividend of $0.44Grifols, S.A. (NASDAQ:GRFS) Announces Semi-annual Dividend of $0.44
americanbankingnews.com - May 26 at 5:12 PM
GigaGen Publishes Research Describing Potential New Avenues - GlobeNewswireGigaGen Publishes Research Describing Potential New Avenues - GlobeNewswire
globenewswire.com - May 25 at 12:30 PM
GigaGen Publishes Research Describing Potential New Avenues to Overcome Resistance to anti-PD-L1 TherapiesGigaGen Publishes Research Describing Potential New Avenues to Overcome Resistance to anti-PD-L1 Therapies
finance.yahoo.com - May 25 at 12:30 PM
Blood Transfusion Diagnostics Market Size 2021 | Is Projected to Reach USD 7.08 Billion by 2028, Exhibiting a CAGR of 7.1% - GlobeNewswireBlood Transfusion Diagnostics Market Size 2021 | Is Projected to Reach USD 7.08 Billion by 2028, Exhibiting a CAGR of 7.1% - GlobeNewswire
globenewswire.com - May 24 at 10:02 AM
Form 6-K Grifols SA For: May 21 - StreetInsider.comForm 6-K Grifols SA For: May 21 - StreetInsider.com
streetinsider.com - May 21 at 7:55 AM
Grifols takes another step in the fight against Alzheimers, partners with Ace to open first AMBAR® Center in BarcelonaGrifols takes another step in the fight against Alzheimer's, partners with Ace to open first AMBAR® Center in Barcelona
finance.yahoo.com - May 19 at 8:00 AM
ChinaHuman Serum Albumin Markets Report 2021: In 2020, Annual Growth Rate was 11.3%, A Slow Down Compared to that in 2019 Due to the COVID-19 Epidemic - Forecast to 2025 - Yahoo FinanceChina'Human Serum Albumin Markets Report 2021: In 2020, Annual Growth Rate was 11.3%, A Slow Down Compared to that in 2019 Due to the COVID-19 Epidemic - Forecast to 2025 - Yahoo Finance
finance.yahoo.com - May 12 at 10:50 AM
Investigation Report on Chinas Human Serum Albumin Markets, 2016-2020 & 2021-2025 - ResearchAndMarkets.com - Business WireInvestigation Report on China's Human Serum Albumin Markets, 2016-2020 & 2021-2025 - ResearchAndMarkets.com - Business Wire
businesswire.com - May 10 at 3:55 PM
Form 6-K Grifols SA For: May 04 - StreetInsider.comForm 6-K Grifols SA For: May 04 - StreetInsider.com
streetinsider.com - May 4 at 1:39 PM
Spains Grifols Q1 net profit falls 30% on plasma shortage - NasdaqSpain's Grifols Q1 net profit falls 30% on plasma shortage - Nasdaq
nasdaq.com - May 4 at 1:39 PM
UPDATE 1-Spains Grifols Q1 net profit falls 30% on plasma shortage - ReutersUPDATE 1-Spain's Grifols Q1 net profit falls 30% on plasma shortage - Reuters
reuters.com - May 4 at 8:39 AM
Spains Grifols Q1 net profit falls 30% to 129 mln euro - NasdaqSpain's Grifols Q1 net profit falls 30% to 129 mln euro - Nasdaq
nasdaq.com - May 4 at 8:39 AM
Heres what Wall Street expects from Grifolss earnings reportHere's what Wall Street expects from Grifols's earnings report
markets.businessinsider.com - May 2 at 5:24 PM
Grifols and Andorran government will establish world-class immunology research hub to expand global knowledge of the immune system and develop therapeuticsGrifols and Andorran government will establish world-class immunology research hub to expand global knowledge of the immune system and develop therapeutics
finance.yahoo.com - April 28 at 9:49 AM
Grifols: The Plasma-Supply Disruption Provides An Attractive Entry Point - Seeking AlphaGrifols: The Plasma-Supply Disruption Provides An Attractive Entry Point - Seeking Alpha
seekingalpha.com - April 20 at 5:40 PM
Form 6-K Grifols SA For: Apr 16 - StreetInsider.comForm 6-K Grifols SA For: Apr 16 - StreetInsider.com
streetinsider.com - April 16 at 12:30 PM
GigaGen Publishes Research on Companys Recombinant Hyperimmunes in Nature Biotechnology - StreetInsider.comGigaGen Publishes Research on Company's Recombinant Hyperimmunes in Nature Biotechnology - StreetInsider.com
streetinsider.com - April 15 at 3:07 PM
GigaGen Publishes Research on Company’s Recombinant Hyperimmunes in Nature BiotechnologyGigaGen Publishes Research on Company’s Recombinant Hyperimmunes in Nature Biotechnology
finance.yahoo.com - April 15 at 3:07 PM
Grifols Extends Commitment to World Federation of Hemophilia Humanitarian Aid Program to 2030Grifols Extends Commitment to World Federation of Hemophilia Humanitarian Aid Program to 2030
finance.yahoo.com - April 15 at 10:06 AM
Grifols 2020 Annual Report on Form 20-F filed with the SEC on April 9, 2021Grifols 2020 Annual Report on Form 20-F filed with the SEC on April 9, 2021
finance.yahoo.com - April 9 at 2:04 PM
Insights on the Antithrombin Global Market to 2027 - Featuring CSL Behring, Grifols International & Kedrion Among Others - ResearchAndMarkets.com - Business WireInsights on the Antithrombin Global Market to 2027 - Featuring CSL Behring, Grifols International & Kedrion Among Others - ResearchAndMarkets.com - Business Wire
businesswire.com - April 6 at 6:19 PM
Insights on the Antithrombin Global Market to 2027 - Featuring CSL Behring, Grifols International & Kedrion Among Others - ResearchAndMarkets.com - Yahoo FinanceInsights on the Antithrombin Global Market to 2027 - Featuring CSL Behring, Grifols International & Kedrion Among Others - ResearchAndMarkets.com - Yahoo Finance
finance.yahoo.com - April 6 at 1:18 PM
Grifols announces topline data from NIAID Phase 3 ITAC trial (INSIGHT-013) evaluating hyperimmune globulins as a treatment for hospitalized patients with COVID-19Grifols announces topline data from NIAID Phase 3 ITAC trial (INSIGHT-013) evaluating hyperimmune globulins as a treatment for hospitalized patients with COVID-19
finance.yahoo.com - April 2 at 1:10 PM
Grifols Procleix UltrioPlex E and Procleix Babesia assays receive CE mark - Yahoo FinanceGrifols Procleix UltrioPlex E and Procleix Babesia assays receive CE mark - Yahoo Finance
finance.yahoo.com - March 25 at 8:08 AM
GigaGen to Present Poster at the 2021 American Association for Cancer Research (AACR) Virtual Annual Meeting - GlobeNewswireGigaGen to Present Poster at the 2021 American Association for Cancer Research (AACR) Virtual Annual Meeting - GlobeNewswire
globenewswire.com - March 24 at 5:24 AM
GigaGen to Present Poster at the 2021 American Association for Cancer Research (AACR) Virtual Annual MeetingGigaGen to Present Poster at the 2021 American Association for Cancer Research (AACR) Virtual Annual Meeting
finance.yahoo.com - March 23 at 2:22 PM
Grifols installs first-ever DG Reader Net analyzer in North AmericaGrifols installs first-ever DG Reader Net analyzer in North America
finance.yahoo.com - March 22 at 1:18 PM
Grifols launches patient point-of-care system for monitoring infliximab in Europe - Yahoo FinanceGrifols launches patient point-of-care system for monitoring infliximab in Europe - Yahoo Finance
finance.yahoo.com - March 18 at 9:37 AM
World Acute On Chronic Liver Failure (ACLF) Market Epidemiology and Forecast to 2030, Featuring Grifols Therapeutics, RHEACELL, Versantis and Martin Pharmaceuticals - Yahoo FinanceWorld Acute On Chronic Liver Failure (ACLF) Market Epidemiology and Forecast to 2030, Featuring Grifols Therapeutics, RHEACELL, Versantis and Martin Pharmaceuticals - Yahoo Finance
finance.yahoo.com - March 11 at 8:46 PM
Grifols reinforces its innovation strategy after completing the acquisition of GigaGen to boost a novel method to generate a wide range of immunoglobulinsGrifols reinforces its innovation strategy after completing the acquisition of GigaGen to boost a novel method to generate a wide range of immunoglobulins
finance.yahoo.com - March 9 at 8:11 AM
Alkahest to Present Positive Data from Completed Phase 2 Clinical Trial at the 15th International Conference on Alzheimers and Parkinsons Disease - GlobeNewswireAlkahest to Present Positive Data from Completed Phase 2 Clinical Trial at the 15th International Conference on Alzheimer's and Parkinson's Disease - GlobeNewswire
globenewswire.com - March 8 at 5:56 PM
Alkahest to Present Positive Data from Completed Phase 2 Clinical Trial at the 15th International Conference on Alzheimer’s and Parkinson’s DiseaseAlkahest to Present Positive Data from Completed Phase 2 Clinical Trial at the 15th International Conference on Alzheimer’s and Parkinson’s Disease
finance.yahoo.com - March 8 at 5:56 PM
Moving Average Crossover Alert: Grifols - Yahoo FinanceMoving Average Crossover Alert: Grifols - Yahoo Finance
finance.yahoo.com - March 8 at 12:54 PM
Moving Average Crossover Alert: GrifolsMoving Average Crossover Alert: Grifols
finance.yahoo.com - March 8 at 12:54 PM
New Strong Sell Stocks for March 8thNew Strong Sell Stocks for March 8th
finance.yahoo.com - March 8 at 12:54 PM
Grifols fosters worlds first scientific journal specialized in blood plasmaGrifols fosters world's first scientific journal specialized in blood plasma
finance.yahoo.com - March 8 at 7:54 AM
Grifols acquires 25 U.S.-based plasma centers from BPL - Seeking AlphaGrifols acquires 25 U.S.-based plasma centers from BPL - Seeking Alpha
seekingalpha.com - March 1 at 6:20 PM
Spains Grifols 2020 net profit falls 1.1% due to coronavirus impact - ReutersSpain's Grifols 2020 net profit falls 1.1% due to coronavirus impact - Reuters
reuters.com - February 26 at 5:39 PM
Spains Grifols 2020 net profit falls 1.1% due to coronavirus impact - Yahoo FinanceSpain's Grifols 2020 net profit falls 1.1% due to coronavirus impact - Yahoo Finance
finance.yahoo.com - February 26 at 12:38 PM
This page was last updated on 6/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.